Cost effective of cervical cancer screening

Abstract

Cervical cancer continues to be a large public health problem in many developing countries because access to screening and treatment of pre-cancerous lesions is not widespread. Recent studies have demonstrated the potential of VIA as an alternative screening test to the Pap smears to identify pre-cancerous lesions. Besides its low cost and the potential to be provided at lower levels of the health system by non-physicians, a key advantage is that, the results of VIA testing are immediately abnormal, can be made during women’s initial visit.